pentobarbital will lessen the extent or result of alfuzosin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital decreases amounts of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Strong CYP3A4 inducers can decrease panobinostat amounts by ~70% and produce cure failure.
pentobarbital will minimize the extent or effect of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
C: Use with caution if benefits outweigh threats. Animal scientific tests demonstrate threat and human research not available or neither animal nor human experiments performed.
Observe Intently (1)pentobarbital will lower the level or influence of tadalafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or outcome of parecoxib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.
Observe Closely (1)pentobarbital will lower the extent or influence of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. CYP3A4 inducers have not been researched, coadministration not click here proposed by manufacturer
pentobarbital will lessen the level or impact of sunitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the level or impact of verapamil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or outcome of irinotecan liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will minimize the level or influence of lopinavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will reduce the extent or effect of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or outcome of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will reduce the extent or impact of finasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.